Previous Close | 16.6 |
1-Year Change | -40.61% |
6-Months Change | -46.14% |
3-Months Change | 18.74% |
Moving Avg (50d) | 15.806 |
Moving Avg (200d) | 23.052 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 0.771B |
Beta (3-Years) | 0.69 |
Revenue Growth (ttm) | 1.78% |
Net Profit Margin (ttm) | 1.05% |
Return On Assets (ttm) | 0.46% |
EPS (ttm) | 0.09 |
PE Ratio (ttm) | 184.44 |
Dividend Yield | % |
Asset Description: | Pacira BioSciences, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Neutral |
Forecast Date: | 2024-10-31 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
17.371 | 17.882 | 18.222 | 18.733 | 19.585 | 20.436 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Pharmaceuticals |
Country: | United States |